THOMPSON JOHN CRAIG

Chief Commercial Officer at Trius Therapeutics Inc · on record since Jan 11, 2011
Director at Esperion Therapeutics, Inc. · on record since Jun 1, 2026
Chief Operating Officer at TETRAPHASE PHARMACEUTICALS INC · on record since Feb 5, 2014
Director at Anthera Pharmaceuticals Inc · on record since Dec 6, 2016
President & CEO at Anthera Pharmaceuticals Inc · on record since Mar 3, 2017

Insider trading activity of THOMPSON JOHN CRAIG

Transactions on record: 42; since Jan 11, 2011

Open-market buys: 3; $27K

Open-market sells: 7; $4M

Companies traded: 4; last filing Jul 13, 2026

Figures computed from official regulatory filings — .

Companies where THOMPSON JOHN CRAIG has traded

Esperion Therapeutics, Inc.4 tx · Jul 13, 2026
Anthera Pharmaceuticals Inc9 tx · $30.1K · Jan 9, 2018
TETRAPHASE PHARMACEUTICALS INC21 tx · $5.3M · Sep 10, 2015
Trius Therapeutics Inc8 tx · $3.1M · Sep 13, 2013

Track record of THOMPSON JOHN CRAIG

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of THOMPSON JOHN CRAIG

Co-insiders of THOMPSON JOHN CRAIG

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Esperion Therapeutics, Inc.Security delisted	Jul 13, 2026	Other	-79,873	—	n/a (No price was disclosed in the filing)		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 13, 2026	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
Esperion Therapeutics, Inc.Security delisted	Jun 1, 2026	Award	79,873	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 2, 2025	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Jan 9, 2018	AwardD (derivative)	1,847,074	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Sep 20, 2017	Buy	8,550	1.32 USD	$11.3K	conv 73	SEC
Anthera Pharmaceuticals IncListing on record	Sep 7, 2017	Buy	10,400	1.43 USD	$14.9K	conv 94First in 12mo	SEC
Anthera Pharmaceuticals IncListing on record	May 22, 2017	AwardD (derivative)	81,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Mar 3, 2017	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Mar 3, 2017	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Feb 6, 2017	Award	7,190	0.55 USD	$4K		SEC
Anthera Pharmaceuticals IncListing on record	Dec 6, 2016	AwardD (derivative)	300,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Jun 13, 2016	AwardD (derivative)	170,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Sep 10, 2015	Sell	-10,000	44.08 USD	$440.8K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Sep 10, 2015	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Sep 10, 2015	Exercise	10,000	14.45 USD	$144.5K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Aug 7, 2015	Exercise	10,000	14.45 USD	$144.5K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Aug 7, 2015	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Aug 7, 2015	Sell	-10,000	46.31 USD	$463.1K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jul 8, 2015	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jul 8, 2015	Sell	-10,000	47.91 USD	$479.1K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jul 8, 2015	Exercise	10,000	14.45 USD	$144.5K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jun 16, 2015	Exercise	10,000	14.45 USD	$144.5K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jun 16, 2015	Sell	-10,000	41.51 USD	$415.1K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jun 16, 2015	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Esperion Therapeutics, Inc.Security delisted	Jul 13, 2026	Other	-79,873	—	n/a (No price was disclosed in the filing)		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 13, 2026	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
Esperion Therapeutics, Inc.Security delisted	Jun 1, 2026	Award	79,873	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Esperion Therapeutics, Inc.Security delisted	Jul 2, 2025	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Jan 9, 2018	AwardD (derivative)	1,847,074	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Sep 20, 2017	Buy	8,550	1.32 USD	$11.3K	conv 73	SEC
Anthera Pharmaceuticals IncListing on record	Sep 7, 2017	Buy	10,400	1.43 USD	$14.9K	conv 94First in 12mo	SEC
Anthera Pharmaceuticals IncListing on record	May 22, 2017	AwardD (derivative)	81,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Mar 3, 2017	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Mar 3, 2017	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Feb 6, 2017	Award	7,190	0.55 USD	$4K		SEC
Anthera Pharmaceuticals IncListing on record	Dec 6, 2016	AwardD (derivative)	300,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Anthera Pharmaceuticals IncListing on record	Jun 13, 2016	AwardD (derivative)	170,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Sep 10, 2015	Sell	-10,000	44.08 USD	$440.8K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Sep 10, 2015	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Sep 10, 2015	Exercise	10,000	14.45 USD	$144.5K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Aug 7, 2015	Exercise	10,000	14.45 USD	$144.5K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Aug 7, 2015	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Aug 7, 2015	Sell	-10,000	46.31 USD	$463.1K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jul 8, 2015	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jul 8, 2015	Sell	-10,000	47.91 USD	$479.1K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jul 8, 2015	Exercise	10,000	14.45 USD	$144.5K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jun 16, 2015	Exercise	10,000	14.45 USD	$144.5K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jun 16, 2015	Sell	-10,000	41.51 USD	$415.1K		SEC
TETRAPHASE PHARMACEUTICALS INCListing unverified	Jun 16, 2015	ExerciseD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC